J&J Medical Connect
CAPLYTA®

(lumateperone)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

CAPLYTA® (lumateperone)
Medical Information

CAPLYTA - Use in Patients with Traumatic Brain Injury

Last Updated: 03/16/2026

SUMMARY  

  • CAPLYTA has not been studied in and is not approved for the treatment of patients with psychosis induced by traumatic brain injury.

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) conducted on 12 September 2025 did not identify any relevant citations pertaining to this topic.

Would you like to clear and leave your conversation? Message history will be lost.